Discoidin domain receptor 2 signaling networks and therapy in lung cancer

Por Payne, Leo S., Huang, Paul H.
Publicado no J Thorac Oncol (2014)

The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients

Por Sequist, Lecia V., Nagrath, Sunitha, Toner, Mehmet, Haber, Daniel A., Lynch, Thomas J.
Publicado no J Thorac Oncol (2009)

Systematic Reviews and Meta Analysis of Published Studies: An overview and Best Practices

Por Mandrekar, Jayawant N., Mandrekar, Sumithra J.
Publicado em 2011

Elevation of Prostaglandin E(2) in Lung Cancer Patients with Digital Clubbing

Por Kozak, Kevin R., Milne, Ginger L., Bentzen, Søren M., Yock, Torunn I.
Publicado em 2012

Paraneoplastic disorders in thymoma patients

Por Lancaster, Eric, Evoli, Amelia
Publicado no J Thorac Oncol (2014)

Germline EGFR T790M mutation found in multiple members of a familial cohort

Por Yu, Helena A., Arcila, Maria E., Harlan, Megan, Stadler, Zsofia, Ladanyi, Marc, Berger, Michael F., Robson, Mark, Riely, Gregory J.
Publicado no J Thorac Oncol (2014)

Clinician Perspectives on Current Issues in Lung Cancer Drug Development

Por Waqar, Saiama N., Bonomi, Philip D., Govindan, Ramaswamy, Hirsch, Fred R., Riely, Gregory J., Papadimitrakopoulou, Vassiliki, Kazandjian, Dickran, Khozin, Sean, Larkins, Erin, Dickson, Dane J., Malik, Shakun, Horn, Leora, Ferris, Andrea, Shaw, Alice T., Jänne, Pasi A., Mok, Tony S.K., Herbst, Roy, Keegan, Patricia, Pazdur, Richard, Blumenthal, Gideon M.
Publicado no J Thorac Oncol (2016)

Adrenal metastases in lung cancer: Clinical implications of a mathematical model

Por Bazhenova, Lyudmila, Newton, Paul, Mason, Jeremy, Bethel, Kelly, Nieva, Jorge, Kuhn, Peter
Publicado em 2014

Waxing and waning of MET amplification in EGFR mutated NSCLC in response to presence and absence of erlotinib selection pressure

Por Womack, Joel P., Varella-Garcia, Marileila, Camidge, D. Ross
Publicado no J Thorac Oncol (2015)

Clinical impact of high-throughput gene expression studies in lung cancer

Por Beane, Jennifer, Spira, Avrum, Lenburg, Marc E.
Publicado em 2009

MET Receptor Tyrosine Kinase

Por Faoro, Leonardo, Cervantes, Gustavo M., El-Hashani, Essam, Salgia, Ravi
Publicado em 2009

Randomized Phase II Trials: Time for a New Era in Clinical Trial Design

Por Mandrekar, Sumithra J., Sargent, Daniel J.
Publicado em 2010

TGF-β Signaling and the Role of Inhibitory Smads in Non-small Cell Lung Cancer

Por Jeon, Hyo-Sung, Jen, Jin
Publicado em 2010

Lung Cancer Workshop XI: Tobacco-Induced Disease: Advances in Policy, Early Detection and Management: Meeting Report

Por Mulshine, James L., Avila, Rick, Yankelevitz, David, Baer, Thomas M., Estépar, Raul San Jose, Ambrose, Laurie Fenton, Aldigé, Carolyn R.
Publicado no J Thorac Oncol (2015)

PD-L1 Expression in Lung Cancer

Por Yu, Hui, Boyle, Theresa A., Zhou, Caicun, Rimm, David L., Hirsch, Fred R.
Publicado no J Thorac Oncol (2016)

TGF-ß Signaling Pathway in Lung Adenocarcinoma Invasion

Por Toonkel, Rebecca L., Borczuk, Alain C., Powell, Charles A.
Publicado em 2010

All-Comers versus Enrichment Design Strategy in Phase II Trials

Por Mandrekar, Sumithra J., Sargent, Daniel J.
Publicado em 2011

Biomarkers in Early-Stage Non-Small Cell Lung Cancer: Current Concepts and Future Directions

Por Burotto, Mauricio, Thomas, Anish, Subramaniam, Deepa, Giaccone, Giuseppe, Rajan, Arun
Publicado no J Thorac Oncol (2014)

Response to crizotinib/erlotinib combination in a patient with a primary EGFR mutant adenocarcinoma and a primary c-met amplified adenocarcinoma of the lung

Por Dietrich, Martin Frederik, Yan, Shirley Xiao, Schiller, Joan Hoff
Publicado no J Thorac Oncol (2015)

Alectinib Dose Escalation Re-induces Central Nervous System Responses in ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients Relapsing on Standard Dose Alectinib

Por Gainor, Justin F., Chi, Andrew S., Logan, Jennifer, Hu, Ranliang, Oh, Kevin S., Brastianos, Priscilla K., Shih, Helen A., Shaw, Alice T.
Publicado no J Thorac Oncol (2015)